This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Eyegene Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Bo-Young Ahn: Innovator in Diabetic Retinopathy Diagnosis
Introduction
Bo-Young Ahn is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of diabetic retinopathy. His innovative approach utilizes genetic markers to enhance the accuracy of diagnoses.
Latest Patents
Ahn holds a patent for a method for diagnosing diabetic retinopathy by single nucleotide polymorphism, DNA fragment thereof, and primer thereof. This patent discloses a method for diagnosing diabetic retinopathy through the identification of a single nucleotide polymorphism of VEGF and its receptor. This advancement has the potential to improve early detection and treatment of this serious condition.
Career Highlights
Throughout his career, Bo-Young Ahn has worked with various organizations, including Eyegene Inc. and Lee, Na-Gyong. His work has been instrumental in bridging the gap between genetic research and practical medical applications.
Collaborations
Ahn has collaborated with several professionals in his field, including Yang-Je Cho and Oh-Woong Kwon. These partnerships have fostered innovation and contributed to the development of effective diagnostic methods.
Conclusion
Bo-Young Ahn's contributions to the field of diabetic retinopathy diagnosis exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile